Evidence map›Paper›PMID 30719137›Full record

ArticleJournal of Cancer2019

Identification of Putative UL54 (ICP27) Transcription Regulatory Sequences Binding to Oct-1, v-Myb, Pax-6 and Hairy in Herpes Simplex Viruses.

Ying-Ying Wang, Yan-Ning Lyu, Hong-Yi Xin, Jun-Ting Cheng, Xiao-Qin Liu, Xian-Wang Wang, Xiao-Chun Peng, Ying Xiang, Victoria W Xin, Cheng-Biao Lu and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 16 citations in OpenAlex.

  1. Gellan Gum/Alginate Films Containing BiogenicMolecules (Basel, Switzerland) · 2026
    Article
  2. Iranian journal of microbiology · 2024
    Article
  3. Article
  4. Article
  5. The Broad-Spectrum Antiviral Potential of the Amphibian Peptide AR-23.International journal of molecular sciences · 2022
    Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Ying-Ying WangThe First School of Clinical Medicine, Department of Medicine, Yangtze University, Jingzhou, Hubei 434023, China.
Yan-Ning LyuInstitute for Infectious Diseases and Endemic Diseases Prevention and Control, Beijing Center for Diseases Prevention and Control, Beijing, 100013, China.
Hong-Yi XinAnimal Health Biotechnology, Temasek Life Sciences Laboratory, National University of Singapore, Singapore 117604.
Jun-Ting ChengThe First School of Clinical Medicine, Department of Medicine, Yangtze University, Jingzhou, Hubei 434023, China.
Xiao-Qin LiuThe First School of Clinical Medicine, Department of Medicine, Yangtze University, Jingzhou, Hubei 434023, China.
Xian-Wang WangThe First School of Clinical Medicine, Department of Medicine, Yangtze University, Jingzhou, Hubei 434023, China.
Xiao-Chun PengThe First School of Clinical Medicine, Department of Medicine, Yangtze University, Jingzhou, Hubei 434023, China.
Ying XiangThe First School of Clinical Medicine, Department of Medicine, Yangtze University, Jingzhou, Hubei 434023, China.
Victoria W XinMontgomery Blair High School Magnet Program Class of 2020, Silver Spring, MD 20901-2451, USA.
Cheng-Biao LuLaboratory of Neuronal Network and Brain Diseases Modulation, School of Medicine, Yangtze University, Jingzhou, Hubei Province, China.
Bo-Xu RenThe First School of Clinical Medicine, Department of Medicine, Yangtze University, Jingzhou, Hubei 434023, China.
Yan-Fang LiangDepartment of Radiology, Guangzhou Medical University Cancer Hospital, Guangzhou, China.
Jia-Fu JiGastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Zhaowu MaThe First School of Clinical Medicine, Department of Medicine, Yangtze University, Jingzhou, Hubei 434023, China.
Shu-Zhong CuiDepartment of Theromotherapy, Guangzhou Medical University Cancer Hospital, Guangzhou, China.
Hong-Wu XinThe First School of Clinical Medicine, Department of Medicine, Yangtze University, Jingzhou, Hubei 434023, China.
Yangtze University · CNGuangzhou Medical University · CNNational University of Singapore · SGBeijing Center for Disease Prevention and Control · CNMontgomery High School · USPeking University Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An oncolytic herpes simplex virus (oHSV) has proven amenable in oncolytic virotherapy and was approved to treat melanoma. The immediate-early (IE) protein ICP27 encoded by gene UL54 is essential for HSV infection. Post-transcriptional modification of UL54 would increase tumor targeting of oHSVs. However, UL54 gene transcription regulatory sequences and factors were not reported yet. Here we isolated a new strain LXMW of type 1 HSV (HSV-1-LXMW) in China and found it's closely related to HSV-1 strains Patton and H129 in the US by the first and next generation DNA sequencing viral DNA phylogenetic analysis. Using a weight matrix-based program Match, we found the UL54 transcription regulatory sequences binding to the transcription factors Oct-1, v-Myb and Pax-6 in HSV-1-LXMW, while the sequences binding to Oct-1 and Hairy in a HSV-2 strain. Further validation showed that HSV-1 and HSV-2 shared the common sequence binding to Oct-1, but had unique sequences to bind v-Myb and Pax-6, or Hairy, respectively, by DNA sequence alignment of total 11 HSV strains. The published results howed that the expression of transcription factors is consistent with the tissue tropism of HSV-1 and HSV-2. In the current article a new HSV-1 strain LXMW was isolated and its putative HSV UL54 transcription regulatory sequences and factors were identified for the first time. Our findings highlight the new understanding of the principles of transcriptional regulation in HSV biology and oncolytic virotherapy.

Indexed as

Infected Cell Polypeptide 27 (ICP27)Long Unique Region 54 (UL54)Oncolytic Herpes Simplex Virus (oHSV)RNA polymerase II (RNAP II)Transcription Factor (TF)Transcription Regulatory Sequence

Identifiers

PMID30719137
PMCPMC6360293
OpenAlexW2908836828

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.